コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 hybrid lymphocyte that expresses both B and T cell receptors.
2 constant alpha and beta domains of the human T-cell receptor, a technology known as bispecific engage
3 lin BTN3A1 inhibits tumor-reactive alphabeta T cell receptor activation by preventing segregation of
5 K) has been shown to play a critical role in T cell receptor activation-induced remodeling of energy
7 ral TCRs (e.g., immune-mobilizing monoclonal T cell receptors against cancer [ImmTAC] molecules), whe
9 intra- and inter-method reproducibility for T cell receptor alpha (TRA) and T cell receptor beta (TR
10 e-based single-cell RNA sequencing of paired T cell receptor alpha and beta chain sequences show pron
11 r staining and coexpression of CD161 and the T-cell receptor alpha variable gene TRAV1-2 were strongl
12 ures of immunoglobulin H (IgH), Igkappa, and T cell receptor-alpha (TCRalpha) loci during B lymphopoi
14 iles of immune cells, coupled with assembled T cell receptor and B cell receptor sequences, we analyz
15 pathways affected in these disorders include T cell receptor and B cell receptor signaling, cytokine
16 also identified Epstein-Barr virus-specific T cell receptors and EBV(+) lymphocytes in the affected
18 The tyrosine phosphatase PTPN2 attenuates T-cell receptor and cytokine signaling in T cells to mai
19 ing of automatically prepared libraries from T-cell receptor and immunoglobulin gene rearrangements i
20 mple, transcriptional activation of both the T-cell receptor and programmed cell death protein 1 path
21 ive cell therapy, including chimeric antigen T-cell receptors and other novel T-cell receptor-based t
22 nx, but OT1 mice fail to do so because their T cell receptors are engineered to recognize a single ov
23 igands for stimulation and co-stimulation of T-cell receptors are presented via the fluid, synthetic
25 family tyrosine kinase (LYN), zeta chain of T-cell receptor-associated protein kinase 70 (ZAP-70), a
28 TOF) and next-generation sequencing of B and T cell receptor (BCR and TCR) repertoires, we demonstrat
29 a repository of currently >14 million B and T cell receptor (BCR and TCR) sequences from the blood o
32 quency, which prompted us to investigate the T cell receptor beta (TCRbeta) repertoire in the CP and
35 anistically, this was a T cell-intrinsic and T cell receptor beta-chain variable-dependent phenomenon
36 k adaptive immunity had no lung disease, and T-cell receptor beta chain (Tcrb)(-/-) STING N153S anima
41 ssociated with oligoclonality and restricted T-cell receptor beta-chain V-J pairing in CD8(+) but not
42 e class T epitope on SEB overlapped with the T-cell receptor binding site, whereas other evidence sug
43 II complex stability, beta167-169 RGD loop, T-cell receptor binding, formation of homodimer of alpha
47 type, transcriptome, epigenetic profile, and T cell receptor clonotype, the authors provide evidence
50 around anchor pockets 1 and 9, as potential T-cell receptor contacts, in the areas for CD4 binding a
52 least 91 unique clones expressing different T-cell receptors) directed against HLA*02:01-restricted
57 avior in mice and was partially dependent on T cell receptor engagement and commensal-derived signals
58 tched, control C57BL/6 mouse LNSC suppressed T-cell receptor engagement by anti-CD3/CD28 via MHC-inde
60 a recombinant CHIKV strain encoding a CD8(+) T cell receptor epitope from ovalbumin, as well as a vir
63 owed TCR V-beta repertoire usage and diluted T-cell receptor excision circles confirm that DN T cells
65 CD8+ Tem and Temra cells showed some unique T cell receptor features in terms of overlap and variabl
67 ficile infection showed increased IL-17A and T cell receptor gamma chain expression, and IL-17 produc
68 e, but molecular testing identified the same T-cell receptor gamma rearrangement present in the gastr
70 functional avidity of selected gamma9delta2 T cell receptors (gamma9delta2TCRs), was not associated
71 merase chain reaction-based investigation of T-cell receptor gene rearrangement to detect clonality.
73 cell clones through paired sequencing of the T cell receptor genes and high-dimensional single-cell s
74 combination assembles and diversifies Ig and T cell receptor genes in developing B and T lymphocytes.
76 ulation critically enhanced signaling by the T cell receptor in the formation of functional immune sy
78 rming deep single-cell sequencing of RNA and T cell receptors in patients with different types of can
79 ofiles of various populations of T cells and T cell receptors in tumours, normal adjacent tissue, and
82 The effectiveness of pathogen detection by T cell receptor is limited by chemical similarity of for
84 to reach the stationary concentration of the T-cell-receptor-ligand-activated complex, which transfer
85 on of a network of inhibitory and activating T cell receptors may be a critical step in the developme
87 ory triggers that can enhance or even bypass T cell receptor-mediated signals-substantially broadenin
88 synapse is classically described between the T-cell receptor of CD4-positive lymphocytes and MHC II o
89 d presentation of a resulting peptide to the T cell receptor on classical peptide-recognizing CD4(+)
91 lls coengineered with a Fas DNR and either a T cell receptor or chimeric antigen receptor exhibited e
96 on of T cells, measured through increases of T-cell receptor productive frequencies, mirrored ctDNA r
97 onse, profound immune exhaustion with skewed T cell receptor repertoire and broad T cell expansion.
103 (UC) using single-cell transcriptomics with T-cell receptor repertoire analysis and mass cytometry.
106 ell carcinomas and correlated metrics of the T-cell receptor repertoire with clinicopathologic charac
107 immune-monitoring reveals remodeling of the T-cell receptor repertoire with immunodominant clones an
108 transport into the endoplasmic reticulum and T-cell receptor repertoire, also contribute to the immun
110 d ability to induce c-Jun/AP-1 expression on T cell receptor restimulation, a mechanism that may cont
111 ate-like T cells expressing a semi-invariant T cell receptor restricted to the non-classical MHC clas
113 matical modeling and statistical analyses of T cell receptor sequencing data, we develop a quantitati
115 enrichment of immune-related processes, and T cell receptor sequencing revealed increased clonality
117 tumors, we conducted whole genome, RNA, and T-cell receptor sequencing, immunohistochemistry and rev
118 solve the spatial and temporal resolution of T cell receptor signaling in the context of immune respo
119 ever, the relative contributions of IL-2 and T cell receptor signaling to this process are unknown.
120 tyrosine phosphosites that mediate proximal T cell receptor signaling, cytoskeletal organization, an
121 Here, we review the current understanding of T-cell receptor signaling and their intersection with IC
122 TNFalpha (tumor necrosis factor-alpha), and T-cell receptor signaling pathways, cytokines involved i
125 h CD8 T cells engineered to express anti-SIV T-cell receptor specificities enables direct experimenta
126 hibiting T cell proliferation in response to T cell receptor stimulation and mediating fibroblast cel
129 s in TILs was induced by the coordination of T cell receptor stimulation, microenvironmental stressor
130 vels of peripheral blood engraftment with E6 T-cell receptor T cells 1 month after treatment (median,
135 analyzing the cytokine production following T cell receptor (TCR) and co-receptor stimulation with a
136 perior antitumor reactivity, we isolated the T cell receptor (TCR) and demonstrated specific recognit
139 immune tolerance whose activity depends upon T cell receptor (TCR) and mTORC1 kinase signaling, but t
140 four previously described Valpha3.2 Vbeta14 T cell receptor (TCR) cDNAs, the dominant clonotype gene
142 hat a subpopulation of T cells expresses two T cell receptor (TCR) clonotypes, though the extent and
145 itive selection in the thymus when their new T cell receptor (TCR) engages and signals in response to
148 T cell maturation and activation depend upon T cell receptor (TCR) interactions with a wide variety o
150 imeric antigen receptor (CAR) or a classical T cell receptor (TCR) is revolutionizing cancer treatmen
151 Moreover, neoantigen-reactive T cells and a T cell receptor (TCR) isolated from the CD8+PD-1+ subset
155 cells engineered to express an HBV-specific T cell receptor (TCR) may achieve cure of HBV infection
156 gy to study OT-1 T cells, revealing that the T cell receptor (TCR) mechanically samples antigens carr
158 l-mediated immunity is governed primarily by T cell receptor (TCR) recognition of peptide-human leuko
159 de CRISPR-Cas9 screening to establish that a T cell receptor (TCR) recognized and killed most human c
161 r TILs, TSA-reactive TILs possess a distinct T cell receptor (TCR) repertoire and unique gene feature
162 respond to nickel but the involved alphabeta T cell receptor (TCR) repertoire has not been comprehens
165 of mice and humans we demonstrate that their T cell receptor (TCR) repertoire is highly diverse and i
168 ported by a combination of immunophenotypic, T cell receptor (TCR) repertoire, functional, and transc
172 t peptidome variation contributes to shaping T cell receptor (TCR) repertoires and hence individual i
174 ation of commonalities and differences among T cell receptor (TCR) repertoires from different individ
178 clude selecting an appropriate repertoire of T cell receptor (TCR) self-affinities in the thymus, reg
181 We utilized the complementary approaches of T cell receptor (TCR) sequencing and cytometry by time-o
182 ere assessed with single-cell RNA and paired T cell receptor (TCR) sequencing of 30,604 T cells from
183 Herein, we perform genome-wide DNA, RNA, and T cell receptor (TCR) sequencing on 29 cutaneous gammade
185 In this issue of the JCI, Ogongo et al. used T cell receptor (TCR) sequencing to characterize unconve
187 ntified an interaction between Trib1 and the T cell receptor (TCR) signaling activator, MALT1, which
188 T cells through the phosphatase SHP1 reduced T cell receptor (TCR) signaling and preformed CD40 ligan
189 It is known that antigen recognition and T cell receptor (TCR) signaling depend on forces applied
192 re, single-cell RNA sequencing revealed that T cell receptor (TCR) signalling was enhanced in these c
194 ity in BDC2.5XNOD mice carrying a transgenic T cell receptor (TCR) specific for a beta cell autoantig
195 nt cardiac autoantigen and that T cells with T cell receptor (TCR) specificity to MYHCA acquired a Tr
197 Moreover, NKT2 cells receive and require T cell receptor (TCR) stimulation for continuous IL-4 pr
199 ng an antibody-based binding domain fused to T cell receptor (TCR) subunits can effectively reprogram
200 ted by signaling molecules downstream of the T cell receptor (TCR) that are organized by adaptor prot
203 (SEB), which naturally links a proportion of T cell receptor (TCR) Vbeta subtypes to MHC-II, present
204 integrates signal strength downstream of the T cell receptor (TCR) within activated thymocytes and pe
205 l, we report that, similar to the endogenous T cell receptor (TCR), antigen engagement triggers the f
207 ule Qa-1, which disrupts Qa-1 binding to the T cell receptor (TCR)-CD8 complex and impairs the CD8 Tr
208 mmadelta T cell population that respond in a T cell receptor (TCR)-dependent manner to phosphoantigen
209 pivotal regulators of immune tolerance, with T cell receptor (TCR)-driven activated T reg (aT reg) ce
211 dozens of unique barcoded templates into the T cell receptor (TCR)-locus revealed gene constructs tha
212 e.g., virus-infected cells, which depends on T cell receptor (TCR)-mediated activation of beta(2)-int
220 molecular modeling, we established that the T cell receptor (TCR):CD3 complex is required for USSN-i
221 on concurrent signaling by Notch and the pre-T cell receptor (TCR); however, it is unclear how these
222 ineering chimeric antigen receptors (CAR) or T cell receptors (TCR) helps create disease-specific T c
224 veloping biomarkers based on analysis of the T-cell receptor (TCR) alpha repertoire to assist in the
226 iciencies received 155 mismatched grafts: 30 T-cell receptor (TCR) alphabeta/CD19-depleted grafts, 43
227 tivation by enabling interaction between the T-cell receptor (TCR) and human leukocyte antigen class
229 omote activation of T cells by strengthening T-cell receptor (TCR) binding to cognate peptide-MHC com
230 ) can be used to determine paired alpha/beta T-cell receptor (TCR) clonotypes in single cells or perf
231 (9-23)) specificity, and mutation of the key T-cell receptor (TCR) contact residue within the epitope
232 peptide elution, mixed lymphocyte reaction, T-cell receptor (TCR) deep sequencing, tetramer-guided n
233 y and clonality index of T cells by means of T-cell receptor (TCR) immunosequencing in a discovery da
235 e clone size distribution of the human naive T-cell receptor (TCR) repertoire is an important determi
239 udy, we developed statistical classifiers of T-cell receptor (TCR) repertoires that distinguish tumor
240 with a substantial increase in the number of T-cell receptor (TCR) sequences and their cognate antige
245 ine residues in response to Listeria-induced T-cell receptor (TCR) stimulation in both naive and memo
246 d tissue and generated an affinity-optimized T-cell receptor (TCR) with specificity to AFP/HLA-A*02(+
247 or a range of immunoreceptors, including the T-cell receptor (TCR), and show that this generic ligand
248 ng through multiple receptors, including the T-cell receptor (TCR), co-receptors, and cytokine recept
249 ructural determinants with those utilized by T-cell receptor (TCR), killer-cell immunoglobulin-like r
252 d in many immune responses, mediated through T-cell receptor (TCR)-dependent and/or independent activ
257 n the binding of pathogenic superantigens to T cell receptors (TCRs) and/or major histocompatibility
259 cells engineered to express antigen-specific T cell receptors (TCRs) are potent therapies for viral i
261 can correctly identifies cognate antigens of T cell receptors (TCRs) from viral and human genome-wide
262 histocompatibility complex (pMHC) ligand for T cell receptors (TCRs) is inactive from solution yet ca
264 ntiation (CD)8(+) T cells, by means of their T cell receptors (TCRs) recognizing intracellular target
265 cocultured T cells expressing MCPyV-specific T cell receptors (TCRs) show increased cytokine producti
266 e of Vdelta1, three CD1b-specific gammadelta T cell receptors (TCRs) showed clear differences in the
268 threats in an antigen-specific manner using T cell receptors (TCRs) that recognize short peptide ant
269 e distinctive nature of DURTs and gammadelta T cell receptors (TCRs) to investigate the involvement o
271 High-avidity CBFB-MYH11 epitope-specific T cell receptors (TCRs) transduced into CD8+ T cells con
273 eron-gamma-producing Vdelta1(+) IELs bearing T cell receptors (TCRs) with a shared non-germline-encod
274 ng the associations of particular gammadelta T cell receptors (TCRs) with specific anatomical sites.
281 sly described GLIPH, an algorithm to cluster T-cell receptors (TCRs) that recognize the same epitope
283 gineered T cells expressing antigen-specific T-cell receptors (TCRs), is an appealing therapeutic app
288 ex (MHC) class I, MHC class II and alphabeta T cell receptors, the antigenic specificity of the gamma
292 ribe a variant of spontaneous EAE in the 2D2 T cell receptor transgenic mouse (2D2(+) mouse) that pre
296 trate rigidity, implying that early steps in T cell receptor triggering are not mechanosensitive.
298 ransmit signals akin to those from activated T-cell receptors when bound to a cell surface target.
299 enes such as IFNA, MRC1, immunoglobulins and T-cell receptors which contribute to defend against path
300 utic strategy combining an affinity-enhanced T Cell receptor with an anti-CD3 T Cell-activating moiet